Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trials Optional

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a Cooperative Agreement to the Duke University’s Duke Clinical Research Institute (DCRI) to support the Clinical Trials Transformation Initiative (CTTI).